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State of art Results (cont.)
Sickle cell anemia (SCA) is caused by the presence of the sickle cell allele-
HBB*S, in homozygosity. In sub-Saharan Africa, HBB*S typically reaches
high frequencies, especially in regions where malaria is endemic.
Epidemiologic evidence indicates that the burden of SCA, which currently
represents a dramatic public health concern in sub-Saharan Africa, will
predictably increase in the future.
In this sense, the determination of prevalence as well as markers of disease
severity are necessary so that the Ministry of Health can develop correct
programs to manage the disease.
The sampling was performed at the General Hospital of Bengo between
Abril 2014 and November 2016, involving the population living in the area
covered by CISA's (the Centro de Investigação em Saúde de Angola) Health
Demographic Surveillance System (Fig 1).
Overall, the Bengo newborns molecularly diagnosed with SCD, including
SCA, summed up 4.5%. Moreover, the most prevalent haplotypes are the
ones with more severity of the disease (Cameroon and Benin). Further
studies are in progress.
We are grateful to the community members who participated in this study, 
and the hospital staff who helped collect the data. 
Fig 1. Study area in Bengo Province
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Children were selected from
maternity, and all children born in
the term in which mothers signed
informed consent, where included.
A total of 359 blood samples,
stored in FTA® (Whatman®), were
analyzed.
Genomic DNA was extracted and
purified using the QIAamp® DNA
Investigator Kit (QIAGEN®). The 2
first exons of the HBB genic region
were amplified and sequenced in a
ABI PRISM 3130xl Analyzer.
The typical SCA alleles HBB*C, HBB*D or HBB*E were not detected in this
sample. Indeed other previous study didn´t found those alleles, or found in
very low frequencies.
However, two polymorphisms associated with thalassemia phenotypes were
detected, namely rs35004220/HbVar.827 and rs11549407/HbVar.845. The
first variant was found in heterozygosity in 4 newborns 2 of them HBB*S
carriers, and the second in 5 newborns 2 of them HBB*S carriers. The
combine frequency of carriers of these two β thalassemia variants was 2,5%
in this sample. Considering as a whole all newborns molecularly diagnosed as
SCD, they accounted to 4,5% of newborns.
The method for analysis of HBB*S haplotypes was based on a Multiplex
SNaPshot® system, which includes 6 SNPs (Fig. 3)The objective of this work was to screen by direct sequencing the HBB gene
in a sample of newborns from Bengo, Angola. Moreover, we aim to identify
common haplotypes of SCA by Multiplex SNaPshot® system.
In addition, in individuals harboring at least one HBB*S allele, a molecular
characterization extended to variations across the β-globin cluster was
performed through a Multiplex SNaPshot® system, aiming to identify the
background haplotypes of HBB*S alleles (Fig 2.)
Table 1. Observed and expected genotypic distribution for HBB*S (rs 334)
Fig 3. Electropherograms examples of SNaPshot® reaction results. 
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Fig 2. Beta Globin cluster´s representation and SNPs analysed by Multiplex 
SNaPshot® system
Overall, this screening revealed the burden of SCA in Bengo is indeed
worrying, with 3.3% of newborns analyzed homozygous for HBB*S (Table 1)
and the estimated frequency of HBB*S in the sample was 0.146, with one in
four being carriers.
The HBB*S haplotype distribution was: 82.93% Cameroon CAR, 9.76% Benin
and 7.31% Senegal. As for the homozygous for the sickle gene, 83.33% were
homozygous for the Cameroon haplotype while the remaining 16.67% were
homozygous for the Benin haplotype. This haplotype distribution has
implications in terms of the clinical course of SCA, since the Cameroon
haplotype was correlated with the lowest levels of fetal hemoglobin and the
more severe SCA phenotypes, being next followed by the Benin haplotype.
By the analysis of the 6 SNPs in 94 samples (12 HBB*S homozygous and 82
heterozygotes) the Arlequim 3,5v software deduced 8 haplotypes. From
those, 4 haplotypes were anchored in HBB*S allele (Table 2).
Table 2. Deduced haplotypes in 94 studied samples. 
